Desmoplastic melanoma with sarcomatoid dedifferentiation.

Desmoplastic melanoma (DM) is a variant of melanoma, which typically affects chronically sun-damaged skin of elderly patients. Pure DM displays a low density of fusiform melanocytes in a collagen-rich matrix. In mixed DM, tumor cell density is higher, and parts of the tumor lack abundant stromal fibrosis. Both pure and mixed DMs usually express S100 protein homogenously. We report herein an unusual biphenotypic tumor characterized by the association of a pure DM with an undifferentiated solid spindle cell nodule. It occurred on the scalp of a 66-year-old man. A biopsy of the undifferentiated spindle cell nodule was initially interpreted at a commercial laboratory as atypical fibroxanthoma. The pure DM was seen only in the excisional specimen. All cells of the pure DM stained for S100 protein and SOX10. The adjacent solid sarcomatoid spindle cell nodule lacked expression of S100 protein, SOX10, as well as melan-A, gp100, and microphthalmia-associated transcription factor in >95% of its tumor cells. Although focal expression of melanocyte differentiation antigens in the solid tumor component made us favor a combined DM with sarcomatoid dedifferentiation, we also considered the possibility of a collision scenario, that is, a pleomorphic dermal sarcoma incidentally colliding with a DM. To further assess a possible relationship of the sarcomatoid nodule with the DM, we performed next-generation sequencing analysis on each component separately. The analysis revealed shared chromosomal copy number changes and a high number of common mutations, thereby supporting the concept of a DM with a dedifferentiated sarcomatoid component. An interesting finding is the presence of mutations of the neurofibromin 1 (NF1) gene in both tumor components.

[1]  A. Armstrong,et al.  Desmoplastic Melanoma , 2020, Definitions.

[2]  G. Salles,et al.  PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. , 2014, The New England journal of medicine.

[3]  M. Berger,et al.  Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: The role of massively parallel sequencing , 2014, Molecular Oncology.

[4]  Cynthia Cohen,et al.  SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal Tissues , 2013, Applied immunohistochemistry & molecular morphology : AIMM.

[5]  David M. Thomas,et al.  Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary , 2013, The Journal of pathology.

[6]  S. Dry,et al.  SOX10 Expression Distinguishes Desmoplastic Melanoma From Its Histologic Mimics , 2013, The American Journal of dermatopathology.

[7]  A. Marghoob,et al.  Desmoplastic melanoma: a review. , 2013, Journal of the American Academy of Dermatology.

[8]  E. Velazquez,et al.  Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi , 2013, Modern Pathology.

[9]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[10]  Janet Kelso,et al.  High‐throughput sequencing of the melanoma genome , 2013, Experimental dermatology.

[11]  C. Sander,et al.  Genome Sequencing Identifies a Basis for Everolimus Sensitivity , 2012, Science.

[12]  A. Hyatt,et al.  Collision of atypical fibroxanthoma and acantholytic squamous cell carcinoma in situ. , 2012, The American Journal of dermatopathology.

[13]  A. Emley,et al.  Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal , 2012, Modern Pathology.

[14]  A. Rademaker,et al.  Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. , 2011, The Journal of molecular diagnostics : JMD.

[15]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[16]  J. Karamchandani,et al.  SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar , 2010, Journal of cutaneous pathology.

[17]  N. Arsenovic,et al.  Trichilemmal cyst with carcinoma in situ within an atypical fibroxanthoma. , 2009, The American Journal of dermatopathology.

[18]  H. Kutzner,et al.  Metastatic Desmoplastic Malignant Melanoma Associated With Low-Grade Myofibroblastic Sarcoma , 2009, The American Journal of dermatopathology.

[19]  N. Polissar,et al.  Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis , 2009, Journal of cutaneous pathology.

[20]  Luis Chiriboga,et al.  Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors , 2008, Journal of cutaneous pathology.

[21]  M. Lens,et al.  Desmoplastic malignant melanoma: a systematic review , 2005, The British journal of dermatology.

[22]  K. Busam Cutaneous Desmoplastic Melanoma , 2005, Advances in anatomic pathology.

[23]  J. Davison,et al.  Absence of V599E BRAF mutations in desmoplastic melanomas , 2005, Cancer.

[24]  D. Coit,et al.  Cutaneous Desmoplastic Melanoma: Reappraisal of Morphologic Heterogeneity and Prognostic Factors , 2004, The American journal of surgical pathology.

[25]  G. Reifenberger,et al.  Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas , 2004, International journal of cancer.

[26]  L. Ben-Porat,et al.  Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma , 2004, Annals of Surgical Oncology.

[27]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[28]  R. Gutzmer,et al.  Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma , 2000, Human Genetics.

[29]  D. Pinkel,et al.  Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. , 2000, The American journal of pathology.

[30]  D. Pinkel,et al.  Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.

[31]  R. Lattes,et al.  Desmoplastic malignant melanoma (A rare variant of spindle cell melanoma) , 1972, Cancer.

[32]  M. Berger,et al.  Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis. , 2014, The American journal of surgical pathology.

[33]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..